-
Drugmakers long ceased to be the only villain of the insulin price scandal. While Lilly is cutting the list price and others may follow, will other "parties" (i.e. pharmacy benefit managers) cause the cost to increase before it hits the pharmacy counter?
-
The moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live.
-
Twitter has been a hotbed for the insulin access movement and activism surrounding other medical conditions - helping propel concern about the prices into policy. Can it continue to win with hashtags?
-
In August, Congress approved a $35 cap on what seniors will pay for insulin, but that change came too late to add to the online tool that helps Medicare beneficiaries compare drug and medical plans.
-
A diabetes diagnosis is not always related to a person’s weight or overall health, especially for those with Type 1 diabetes, who are dependent on insulin treatment for life.
-
The U.S. House is considering a bill to give Medicare the power to negotiate lower costs for prescription drugs like insulin, a life-saving diabetes medicine that can cost families thousands of dollars a year.
-
The price of insulin keeps going up. For people with Type 1 diabetes, high prices can be a life and death issue. Now a grassroots movement is pushing for change.
-
Changing the cannulas or tubes in the insulin pumps is not only painful for patients, but increases their risk of infection.